Follow Us on Google
By Ezekiel David
The World Health Organization (WHO) has declared a global health emergency due to a novel strain of the mpox virus. This is the second time in two years that mpox has sparked significant worries. Although skin sores and flu-like symptoms are the virus’s common symptoms, young people, pregnant moms, and those with weakened immune systems are particularly vulnerable.
Rapid Spread of Clade Ib
The new variant, known as clade Ib, was first detected in the Democratic Republic of Congo (DRC). Unlike earlier variants, this strain is spreading faster, raising concerns as it begins to reach other parts of the world.
Highest Alert: Public Health Emergency of International Concern
The WHO’s declaration of a “public health emergency of international concern” (PHEIC) is their highest level of alert. This status is used when a disease is spreading in unexpected ways and requires a coordinated global response.
Other News
Mpox’s Global Attention Two Years Ago
When a distinct strain, clade IIb, began spreading mostly among men who have sex with men two years ago, mpox became well-known worldwide. Although that outbreak was brought under control, mpox has been a recurring issue in parts of Africa for decades. The current outbreak in Congo is the worst on record, with over 27,000 cases and more than 1,100 deaths reported since the beginning of 2023.
International Spread of Clade Ib
The DRC’s bordering nations of Rwanda, Uganda, Burundi, and Kenya have already experienced the clade Ib strain’s expansion. Its potential to spread farther was shown when Sweden recently confirmed the first case of this strain outside of Africa. Although it is still unclear if this is connected to the new variation, Pakistan has also recorded a case in a patient returning from a Gulf nation.
WHO Calls for Urgent Action
The WHO is calling for a speedier delivery of medical supplies and financial support to Congo, the area most vulnerable to the outbreak. Increased surveillance and quick action are required to identify and contain the infection. However, getting the necessary support has proven to be challenging. The WHO requested $34 million last year to combat mpox, but only a small amount of funding was provided, and vaccination access is still inconsistent, especially in African countries.
Mpox’s Serious Threat Despite Lower Transmission
Even though mpox does not spread as quickly as COVID-19, it is still a major threat, particularly in places with poor access to healthcare. In the Congo, the initial and subsequent strains of this outbreak have caused 4% of deaths. The former clade II was global in distribution and far less deadly. Right now, the most important thing is to make sure that medications and vaccines go to the people who need them the most, especially in the Congo and its neighbouring areas.
